Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Methods in Molecular Biology (Clifton, N.J.)|May 18, 2022
Application of Immunoaffinity Mass Spectrometry (IA-MS) for Protein Biomarker QuantificationJoe Palandra, Nikolaos Psychogios, Hendrik NeubertBiomedical Chromatography : BMC|July 2, 2003
Rapid determination of rat plasma uridine levels by HPLC-ESI-MS utilizing the Captiva plates for sample preparationMarta G Williams, Joe Palandra, Eric M ShobeAnalytical Chemistry|February 13, 2009
LC-MS/MS mediated absolute quantification and comparison of bile salt export pump and breast cancer resistance protein in livers and hepatocytes across speciesNa Li, Joe Palandra, Olga V Nemirovskiy, et al.Analytical Chemistry|May 4, 2013
Highly specific and sensitive measurements of human and monkey interleukin 21 using sequential protein and tryptic peptide immunoaffinity LC-MS/MSJoe Palandra, Alyce Finelli, Ming Zhu, et al.Proteomics. Clinical Applications|February 6, 2016
Quantitative measurements of GDF-8 using immunoaffinity LC-MS/MSJoe Palandra, Amira Quazi, Lori Fitz, et al.Scientific Reports|June 6, 2023
Analysis of β-nerve growth factor and its precursor during human pregnancy by immunoaffinity-liquid chromatography tandem mass spectrometryJason Walsh, Joe Palandra, Eduward Goihberg, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 19, 2009
Endogenous ethanolamide analysis in human plasma using HPLC tandem MS with electrospray ionizationJoe Palandra, Jeff Prusakiewicz, Josef S Ozer, et al.Analytical Chemistry|August 26, 2024
Improving the Sensitivity of Protein Quantification by Immunoaffinity Liquid Chromatography─Triple Quadrupole Mass Spectrometry Using an Iterative Transition Summing TechniqueJay S Johnson, Joe Palandra, Nikolaos Psychogios, et al.Gene Therapy|August 2, 2025
Dystrophin/mini-dystrophin expression analysis by immunoaffinity liquid chromatography-tandem mass spectrometry after gene therapy for DMDJason Walsh, Joe Palandra, Nicole Duriga, et al.Molecular Pharmaceutics|May 12, 2006
Breast cancer resistance protein (Bcrp/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouseHani Zaher, Anis A Khan, Joe Palandra, et al.Pageof 4